Policy & Regulation

The productivity of oncology development continues

Read more

IMI: Building a science infrastructure for Europe

Read more

Chimeric antigen receptor therapy goes global

Read more

EU Commission proposes €100 billion for science

Read more

Innovation spreads across the oncology sector

Read more

Building a European capital market

Read more

How GMO rules affect gene and cell therapies

Read more

MedNous Briefing: FDA policy on digital health

Read more

The rise of single-arm studies in oncology

Read more

Managing the EMA Relocation

Read more